Fida Biosystems
Cameron Parast is an experienced Application Scientist currently working at Fida Biosystems since March 2023 and has held a similar position at Bruker Daltonics since December 2020. Prior to these roles, Cameron served as a Field Application Scientist at Sartorius Stedim North America, Inc. and Danaher Corporation, providing technical support for biolayer interferometry and surface plasmon resonance spectrometers. Cameron's academic background includes teaching chemistry at Skyline College and significant industry experience as a Scientist at Amgen, a Research Scientist at Pfizer and Merck, and a Research Assistant at the University of Maryland, focusing on biochemistry, enzymology, and assay development.
This person is not in any offices
Fida Biosystems
Fida Biosystems offers a new proprietary technology developed for quantification and characterization of proteins and nanoparticles from 0.5 to 1,000 nm Dh, incl. antibodies, liposomes, exosomes, membrane embedded proteins et al. Based on accurate, in-solution, absolute measurements of hydrodynamic radius, the technology provides precise information about Kd, concentration, size, stoichiometry, conformational changes, oligomeric state, immunogenicity, multiple bindings etc. It is characterised by being fast (minutes), requiring very small sample amounts (ul-nl), and being exceptionally tolerant to the sample matrix, incl. plasma, serum, cell lysate, fermentation media etc. Contrary to most other procedures, the methodology is based on binding in homogenous solution; complications related to non-specific surface adsorption and challenging assay development are therefore avoided. I.e. the unique features of the FIDA technology enable characterisation and quantification in native (biorelevant) environments and in-built assay quality control and automation.